Introduction The market access landscape in the Middle East and North Africa (MENA) is dynamic and rapidly changing. MENA is diverse, comprising many dissimilar countries, with different cultures, including languages, used in commerce. The concerns about the long-term sustainability of oil revenues are driving to shape healthcare markets. There are different approaches to regulating healthcare […]
Read allIntroduction Many middle-income countries such as Egypt, South Africa, Malaysia, Thailand, and Brazil have pharmacoeconomic guidelines. These follow the recommendations by the International Society for Pharmacoeconomics and Outcomes Research but include country-specific differences. The variations respond to changes in how governments apply pharmacoeconomics and determine market access to pharmaceuticals and medical devices. This is also […]
Read allTo review highlights of Plenary Session 1 on November 7, 2022: “The Convergence of Health Technology Assessment and Regulation: A New HTA Reality and Collaboration with Regulatory Agencies”.
Read all